arrow_back Search

EFTA00629145

DOJ Epstein Files
folder Dataset 9 insert_drive_file EFTA00629145.pdf description PDF text_fields 320 words · 2.0k chars
open_in_new View original source

From To: "jeffrey E." <jecvacation@gmail.com> Subject: Re: When can we talk again? Date: Mon, 19 Jun 2017 19:53:06 +0000 > Here's what I need help with ... Wednesday and THANK YOU Bgc3 I've been asked to help provide recommendations on bg next steps for ALZHEIMER dementia within the next 3 months. He doesn't want to create a new institution. He's going to invest in an existing fund that is a joint project across a lot of pharma companies. He's interested in (a) biomarkers (b) clinical trial registries. Need a good strategy other than just researching scientists and doing homework for Larry. 6 months ends October 25. Would like to have something great to show for the time. Plants I need an angle to pursue that involves clinical side / humans Next steps I've got another few months w bgc3 and will try to complete endovascular cases over the coming month/year but really want a better "path" - could be vascular/plants but could be elsewhere. Trying to focus and use time well. Biotech? Clinical research +/- Clinical medicine (patient care)? Corporate (Amazon? Google? On the health side)? As you know would like to/need to make money and need to find the right space next... On Mon, Jun 19, 2017 at 12:36 PM, jeffrey E. <jeevacation(iiigmail.com> wrote: Wed On Mon, Jun 19, 2017 at 2:19 PM wrote: Free today, Wednesday and Thur. please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this EFTA00629145 communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeeNS®gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00629146